Jim E Riviere
Overview
Explore the profile of Jim E Riviere including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
178
Citations
1969
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Patel P, Gaddis M, Xu X, Riviere J, Kawakami J, Meyer E, et al.
Heliyon
. 2023 Mar;
9(3):e13763.
PMID: 36855650
Initial studies in COVID-19 patients reported lower mortality rates associated with the use of the drug heparin, a widely used anticoagulant. The objective of this analysis was to determine whether...
12.
Chen Q, Riviere J, Lin Z
Wiley Interdiscip Rev Nanomed Nanobiotechnol
. 2022 Nov;
14(6):e1808.
PMID: 36416026
The rapid growth of nanomaterial applications has raised safety concerns for human health. A number of studies have been conducted to assess the toxicokinetics, toxicology, dose-response, and risk assessment of...
13.
Yuan L, Chou W, Richards E, Tell L, Baynes R, Davis J, et al.
Food Chem Toxicol
. 2022 Aug;
168:113332.
PMID: 35940329
Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) commonly used in food-producing animals, including chickens in an extralabel manner. This study aimed to develop a physiologically based pharmacokinetic (PBPK) model for...
14.
Chou W, Cheng Y, Riviere J, Monteiro-Riviere N, Kreyling W, Lin Z
Part Fibre Toxicol
. 2022 Jul;
19(1):47.
PMID: 35804418
Background: Physiologically based pharmacokinetic (PBPK) modeling is an important tool in predicting target organ dosimetry and risk assessment of nanoparticles (NPs). The methodology of building a multi-route PBPK model for...
15.
Chou W, Tell L, Baynes R, Davis J, Maunsell F, Riviere J, et al.
Toxicol Sci
. 2022 Jun;
188(2):180-197.
PMID: 35642931
Violative chemical residues in edible tissues from food-producing animals are of global public health concern. Great efforts have been made to develop physiologically based pharmacokinetic (PBPK) models for estimating withdrawal...
16.
Lin Z, Chou W, Cheng Y, He C, Monteiro-Riviere N, Riviere J
Int J Nanomedicine
. 2022 Apr;
17:1365-1379.
PMID: 35360005
Background: Low delivery efficiency of nanoparticles (NPs) to the tumor is a critical barrier in the field of cancer nanomedicine. Strategies on how to improve NP tumor delivery efficiency remain...
17.
Mercer M, Davis J, Riviere J, Baynes R, Tell L, Jaberi-Douraki M, et al.
J Am Vet Med Assoc
. 2022 Jan;
260(5):514-523.
PMID: 35092661
No abstract available.
18.
Xu X, Kawakami J, Millagaha Gedara N, Riviere J, Meyer E, Wyckoff G, et al.
Elife
. 2021 Nov;
10.
PMID: 34812146
Background: Potential therapy and confounding factors including typical co-administered medications, patient's disease states, disease prevalence, patient demographics, medical histories, and reasons for prescribing a drug often are incomplete, conflicting, missing,...
19.
Update on withdrawal intervals following extralabel use of procaine penicillin G in cattle and swine
Halleran J, Papich M, Li M, Lin Z, Davis J, Maunsell F, et al.
J Am Vet Med Assoc
. 2021 Nov;
260(1):50-55.
PMID: 34793323
No abstract available.
20.
Richards E, Tell L, Davis J, Baynes R, Lin Z, Maunsell F, et al.
J Am Vet Med Assoc
. 2021 Oct;
259(8):860-873.
PMID: 34609191
No abstract available.